Small Cap IR Issued Analyst Report of Medovex; Developing a Cure for 2nd Most Common Cause of Disability by CapRock Research
NEW YORK, April 29, 2015 /PRNewswire/ -- Analyst Report Issued by Small Cap IR. Lower back pain is the second most common cause of disability in the U.S. for adults. Studies indicate that 10% of the U.S. adult population suffers from lower back pain, and that 31% of lower back pain is attributed to Facet Joint Syndrome (FJS), a condition in which the joints in the back of the spine degenerate and subsequently cause pain. According to estimates by the research organization marketsandmarkets.com, the global spinal implants and surgical equipment market was estimated to be $11.5 billion in revenues in 2012, and is expected to growth at a CAGR of 5.1%, reaching an estimated $14.8 billion by 2017.
Medovex Corporation (NASDAQ: MDVX) is a development stage company incorporated in Nevada, and based in Atlanta, Georgia. The company focuses on obtaining, developing and commercializing various intellectual property rights, which include patents and patent applications in the medical technology area, with particular focus on the development of medical devices. The company's intention is to build a portfolio of medical device products in areas where its management team believes the largest, most targetable market opportunities exist. The company plans on building this portfolio primarily by acquiring companies or technologies that it believes have promising commercial potential.
An analyst report on MDVX that includes a company overview, market and competition breakdown, recent events, outlook, analyst summary, and recommendation can be viewed by using the following link at no cost.
http://bit.ly/-MDVX-AnalystReport
Copy and paste to browser may be required.
About Small Cap IR
We make the connection between sophisticated investors and high quality small cap companies. An issuer of reports written by chartered financial analysts (CFA's) who provide a straightforward assessment of the profiled company and have pledged to remain free of influence when writing research reports. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.
For more information and services provided beyond this release please use contact information provided below.
Forward-Looking Disclaimer
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Compliance Procedure
Content is researched, written and reviewed on a best-effort basis by a Charles I. Reed, CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.
A full disclaimer can be found by viewing the analyst report.
If you wish to have a company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected]. For any urgent concerns or inquiries please contact us at [email protected].
Contact: [email protected]
SOURCE Small Cap IR
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article